We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AMRX market cap is 2.43B. The company's latest EPS is USD -0.2711 and P/E is -21.65.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 617.89M | 629.65M | 659.19M | 701.78M | 702.47M |
Operating Income | 75.65M | 14.19M | -10.65M | 95.47M | 87.78M |
Net Income | 9.68M | -98.65M | -91.64M | 5.99M | -156k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.63B | 1.99B | 2.09B | 2.22B | 2.41B |
Operating Income | -248.68M | 91.16M | 158.08M | -96.84M | 204.37M |
Net Income | -361.92M | 91.06M | 10.62M | -129.99M | -83.99M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.69B | 3.47B | 3.46B | 3.51B | 3.46B |
Total Liabilities | 3.5B | 3.41B | 3.47B | 3.51B | 3.49B |
Total Equity | 154.24M | 20.01M | -63.63M | -57.49M | -93.57M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.67B | 4.01B | 3.94B | 3.8B | 3.47B |
Total Liabilities | 3.32B | 3.65B | 3.56B | 3.59B | 3.41B |
Total Equity | 346.79M | 344.93M | 366.97M | 183.98M | 20.01M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 209.75M | 345.58M | -4.41M | 35.25M | 177.02M |
Investing | -37.5M | -69.19M | -19.76M | -26.23M | -46.94M |
Financing | -111.74M | -212.57M | -23.16M | -58.24M | -150.59M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.71M | 379M | 241.82M | 65.1M | 345.58M |
Investing | -19.58M | -317.55M | -194.18M | -174.31M | -69.19M |
Financing | -45.83M | 131.81M | -138.12M | -106.62M | -212.57M |
Market Cap | 2.43B |
Price to Earnings Ratio | -21.65 |
Price to Sales Ratio | 0.75 |
Price to Cash Ratio | 19.87 |
Price to Book Ratio | 29.67 |
Dividend Yield | - |
Shares Outstanding | 309.84M |
Average Volume (1 week) | 918.56k |
Average Volume (1 Month) | 1.12M |
52 Week Change | 33.16% |
52 Week High | 9.475 |
52 Week Low | 5.01 |
Spread (Intraday) | 0.06 (0.76%) |
Company Name | Amneal Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.amneal.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions